314 related articles for article (PubMed ID: 24698287)
1. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.
Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2014 Dec; 21(12):1451-7. PubMed ID: 24698287
[TBL] [Abstract][Full Text] [Related]
2. Cortical excitability distinguishes ALS from mimic disorders.
Vucic S; Cheah BC; Yiannikas C; Kiernan MC
Clin Neurophysiol; 2011 Sep; 122(9):1860-6. PubMed ID: 21382747
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study.
Menon P; Geevasinga N; Yiannikas C; Howells J; Kiernan MC; Vucic S
Lancet Neurol; 2015 May; 14(5):478-84. PubMed ID: 25843898
[TBL] [Abstract][Full Text] [Related]
4. Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation.
Tankisi H; Nielsen CS; Howells J; Cengiz B; Samusyte G; Koltzenburg M; Blicher JU; Møller AT; Pugdahl K; Fuglsang-Frederiksen A; de Carvalho M; Bostock H
Eur J Neurol; 2021 Sep; 28(9):3030-3039. PubMed ID: 34233060
[TBL] [Abstract][Full Text] [Related]
5. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study.
Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S
Eur J Neurol; 2024 Jul; 31(7):e16281. PubMed ID: 38504632
[TBL] [Abstract][Full Text] [Related]
6. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
[TBL] [Abstract][Full Text] [Related]
7. Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.
Geevasinga N; Menon P; Nicholson GA; Ng K; Howells J; Kril JJ; Yiannikas C; Kiernan MC; Vucic S
JAMA Neurol; 2015 Nov; 72(11):1268-74. PubMed ID: 26348842
[TBL] [Abstract][Full Text] [Related]
8. Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS.
Grieve SM; Menon P; Korgaonkar MS; Gomes L; Foster S; Kiernan MC; Vucic S
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):85-92. PubMed ID: 26458122
[TBL] [Abstract][Full Text] [Related]
9. A new parameter to discriminate amyotrophic lateral sclerosis patients from healthy participants by motor cortical excitability changes.
Cengiz B; Kuruoğlu R
Muscle Nerve; 2020 Mar; 61(3):354-362. PubMed ID: 31875983
[TBL] [Abstract][Full Text] [Related]
10. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS.
Menon P; Kiernan MC; Vucic S
Clin Neurophysiol; 2015 Apr; 126(4):803-9. PubMed ID: 25227219
[TBL] [Abstract][Full Text] [Related]
11. Three different short-interval intracortical inhibition methods in early diagnosis of amyotrophic lateral sclerosis.
Tankisi H; Pia H; Strunge K; Howells J; Cengiz B; Samusyte G; Koltzenburg M; Fuglsang-Frederiksen A; Bostock H
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):139-147. PubMed ID: 35899374
[No Abstract] [Full Text] [Related]
12. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
Vucic S; Kiernan MC
Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
[TBL] [Abstract][Full Text] [Related]
13. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.
Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2017 Jun; 24(6):816-824. PubMed ID: 28436181
[TBL] [Abstract][Full Text] [Related]
14. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
Vucic S; Cheah BC; Kiernan MC
Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
[TBL] [Abstract][Full Text] [Related]
15. Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis.
Higashihara M; Pavey N; van den Bos M; Menon P; Kiernan MC; Vucic S
Neurology; 2021 Apr; 96(16):e2090-e2097. PubMed ID: 33827958
[TBL] [Abstract][Full Text] [Related]
16. Cortical hyperexcitability evolves with disease progression in ALS.
Menon P; Higashihara M; van den Bos M; Geevasinga N; Kiernan MC; Vucic S
Ann Clin Transl Neurol; 2020 May; 7(5):733-741. PubMed ID: 32304186
[TBL] [Abstract][Full Text] [Related]
17. Superconditioning TMS for examining upper motor neuron function in MND.
Calancie B; Young E; Watson ML; Wang D; Alexeeva N
Exp Brain Res; 2019 Aug; 237(8):2087-2103. PubMed ID: 31175383
[TBL] [Abstract][Full Text] [Related]
18. Cortical contributions to the flail leg syndrome: Pathophysiological insights.
Menon P; Geevasinga N; Yiannikas C; Kiernan MC; Vucic S
Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):389-96. PubMed ID: 26888565
[TBL] [Abstract][Full Text] [Related]
19. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
Vucic S; Kiernan MC
Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
[TBL] [Abstract][Full Text] [Related]
20. Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation.
Suzuki YI; Ma Y; Shibuya K; Misawa S; Suichi T; Tsuneyama A; Nakamura K; Matamala JM; Dharmadasa T; Vucic S; Fan D; Kiernan MC; Kuwabara S
J Neurophysiol; 2021 Sep; 126(3):840-844. PubMed ID: 34406906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
